Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

IKAST FYSIOTERAPI III ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   1.5% 1.8% 5.4% 2.9% 3.4% 3.6% 17.0% 16.7%   Credit score (0-100)   78 73 42 56 54 51 10 10   Credit rating   A A BBB BBB BBB BBB BB BB   Credit limit (kDKK)   4.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   432 584 -66 320 383 121 121 121   Gross profit   421 572 -77.8 307 371 100 0.0 0.0   EBITDA   421 572 -77.8 307 371 100 0.0 0.0   EBIT   421 572 -77.8 307 371 100 0.0 0.0   Pre-tax profit (PTP)   420.7 571.0 -78.9 305.9 371.0 105.6 0.0 0.0   Net earnings   327.2 445.4 -61.6 238.5 289.4 82.4 0.0 0.0   Pre-tax profit without non-rec. items   421 571 -78.9 306 371 106 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   904 1,349 1,288 826 715 298 248 248   Interest-bearing liabilities   404 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,470 1,438 1,316 922 818 343 248 248   Net Debt   305 -138 -222 -231 -82.1 -69.6 -248 -248     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   432 584 -66 320 383 121 121 121   Net sales growth   24.8% 35.1% -111.3% -586.6% 19.9% -68.4% 0.0% 0.0%   Gross profit   421 572 -77.8 307 371 100 0.0 0.0   Gross profit growth   25.6% 35.9% 0.0% 0.0% 20.6% -73.0% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,470 1,438 1,316 922 818 343 248 248   Balance sheet change%   -2.1% -2.2% -8.5% -29.9% -11.3% -58.1% -27.7% 0.0%   Added value   420.9 572.0 -77.8 307.3 370.5 100.0 0.0 0.0   Added value %   97.4% 98.0% 118.5% 96.2% 96.7% 82.6% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   1.0 2.0 -1.0 -2.0 1.0 -1.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   97.4% 98.0% 118.5% 96.2% 96.7% 82.6% 0.0% 0.0%   EBIT %   97.4% 98.0% 0.0% 96.2% 96.7% 82.6% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   75.7% 76.3% 93.8% 74.6% 75.5% 68.1% 0.0% 0.0%   Profit before depreciation and extraordinary items %   75.7% 76.3% 93.8% 74.6% 75.5% 68.1% 0.0% 0.0%   Pre tax profit less extraordinaries %   97.4% 97.8% 120.2% 95.7% 96.8% 87.3% 0.0% 0.0%   ROA %   28.3% 39.3% -5.6% 27.5% 43.0% 18.2% 0.0% 0.0%   ROI %   31.6% 42.6% -5.8% 28.6% 48.2% 20.1% 0.0% 0.0%   ROE %   44.2% 39.5% -4.7% 22.6% 37.5% 16.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   61.5% 93.8% 97.8% 89.6% 87.5% 86.9% 100.0% 100.0%   Relative indebtedness %   131.0% 9.9% -9.5% 26.7% 26.7% 5.2% 0.0% 0.0%   Relative net indebtedness %   108.0% -13.7% 328.1% -45.5% 5.2% -52.3% -204.8% -204.8%   Net int. bear. debt to EBITDA, %   72.4% -24.1% 285.0% -75.1% -22.2% -69.6% 0.0% 0.0%   Gearing %   44.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.3 4.7 146.3 5.5 5.4 34.5 0.0 0.0   Current Ratio   0.3 4.7 146.3 5.5 5.4 34.5 0.0 0.0   Cash and cash equivalent   99.3 137.9 221.7 230.8 82.1 69.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 -0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   42.5% 46.8% -1,392.1% 148.1% 144.3% 178.2% 204.8% 204.8%   Net working capital   -382.3 215.6 908.0 387.9 450.6 209.4 0.0 0.0   Net working capital %   -88.5% 36.9% -1,382.6% 121.4% 117.6% 173.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   432 584 -66 320 383 121 0 0   Added value / employee   421 572 -78 307 371 100 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   421 572 -78 307 371 100 0 0   EBIT / employee   421 572 -78 307 371 100 0 0   Net earnings / employee   327 445 -62 238 289 82 0 0